HK Stock MarketDetailed Quotes

08257 GENES TECH

Watchlist
  • 0.063
  • -0.007-10.00%
Market Closed Apr 18 16:08 CST
63.00MMarket Cap2.74P/E (TTM)

GENES TECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
-16.64%1.33B
-3.57%1.11B
25.63%749.51M
35.17%319.92M
6.78%1.6B
-3.49%1.15B
-26.22%596.62M
-42.79%236.69M
-0.03%1.5B
0.14%1.19B
Operating income
-16.64%1.33B
-3.57%1.11B
25.63%749.51M
35.17%319.92M
6.78%1.6B
-3.49%1.15B
-26.22%596.62M
-42.79%236.69M
-0.03%1.5B
0.14%1.19B
Cost of sales
18.38%-1.01B
0.15%-844.68M
-34.37%-539.9M
-39.03%-223.22M
-6.79%-1.23B
7.43%-845.93M
35.94%-401.79M
49.01%-160.56M
-5.21%-1.16B
-3.12%-913.87M
Other costs
----
----
----
----
---257.79M
----
----
----
----
----
Operating expenses
32.49%-1.01B
0.15%-844.68M
-34.37%-539.9M
-39.03%-223.22M
-29.11%-1.49B
7.43%-845.93M
35.94%-401.79M
49.01%-160.56M
-5.21%-1.16B
-3.12%-913.87M
Gross profit
203.27%325.96M
-13.11%263.17M
7.59%209.61M
27.02%96.7M
-68.59%107.48M
9.57%302.88M
7.34%194.82M
-22.97%76.13M
-14.44%342.17M
-8.57%276.43M
Selling expenses
5.83%-57.55M
0.06%-43.93M
-6.21%-28.3M
-33.82%-16.37M
-7.82%-61.11M
-126.59%-43.96M
-122.22%-26.64M
-120.14%-12.23M
-96.87%-56.68M
5.12%-19.4M
Administrative expenses
1.01%-128.99M
0.58%-97.5M
6.32%-62.64M
7.60%-29.81M
15.99%-130.31M
25.52%-98.07M
26.96%-66.87M
34.41%-32.26M
10.50%-155.12M
-6.81%-131.67M
Impairment and provision
391.67%8.65M
----
----
----
57.54%-2.96M
----
----
----
-102.67%-6.98M
---6.54M
-Other impairment is provision
391.67%8.65M
----
----
----
57.54%-2.96M
----
----
----
-102.67%-6.98M
---6.54M
Special items of operating profit
-117.00%-3.21M
45.60%7.2M
-183.27%-7.15M
-271.95%-6.82M
161.71%18.87M
173.01%4.95M
757.50%8.59M
133.18%3.96M
-56.30%7.21M
-80.88%1.81M
Operating profit
312.93%144.86M
-22.23%128.94M
1.47%111.52M
22.78%43.7M
-152.09%-68.03M
37.42%165.79M
56.74%109.9M
-22.24%35.6M
-38.06%130.61M
-28.23%120.65M
Financing income
130.59%1.01M
479.59%568K
557.32%539K
322.22%76K
338.00%438K
36.11%98K
41.38%82K
0.00%18K
-25.93%100K
-27.27%72K
Financing cost
-32.49%-19.59M
-45.19%-14.98M
-54.98%-10.06M
-67.65%-4.96M
-19.72%-14.79M
-9.97%-10.31M
-1.74%-6.49M
9.60%-2.96M
14.13%-12.35M
15.90%-9.38M
Earning before tax
253.29%126.28M
-26.38%114.54M
-1.44%102M
18.88%38.82M
-169.61%-82.38M
39.73%155.58M
62.23%103.49M
-23.21%32.66M
-39.81%118.36M
-29.11%111.34M
Tax
-1,932.54%-35.64M
28.42%-31.04M
15.46%-25.41M
-10.52%-9.93M
104.99%1.95M
-42.73%-43.36M
-75.44%-30.06M
20.62%-8.98M
25.70%-38.95M
29.87%-30.38M
After-tax profit from continuing operations
212.68%90.64M
-25.59%83.5M
4.30%76.59M
22.05%28.9M
-201.30%-80.44M
38.61%112.22M
57.38%73.43M
-24.15%23.68M
-44.94%79.4M
-28.82%80.96M
Earning after tax
212.68%90.64M
-25.59%83.5M
4.30%76.59M
22.05%28.9M
-201.30%-80.44M
38.61%112.22M
57.38%73.43M
-24.15%23.68M
-44.94%79.4M
-28.82%80.96M
Profit attributable to shareholders
212.68%90.64M
-25.59%83.5M
4.30%76.59M
22.05%28.9M
-201.30%-80.44M
38.61%112.22M
57.38%73.43M
-24.15%23.68M
-44.94%79.4M
-28.82%80.96M
Basic earnings per share
212.69%0.0906
-25.58%0.0835
4.36%0.0766
21.94%0.0289
-201.26%-0.0804
38.52%0.1122
57.17%0.0734
-24.04%0.0237
-44.94%0.0794
-28.76%0.081
Diluted earnings per share
212.69%0.0906
-25.58%0.0835
4.36%0.0766
21.94%0.0289
-201.26%-0.0804
38.52%0.1122
57.17%0.0734
-24.04%0.0237
-44.94%0.0794
-28.76%0.081
Currency Unit
TWD
TWD
TWD
TWD
TWD
TWD
TWD
TWD
TWD
TWD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
PricewaterhouseCoopers
--
--
--
PricewaterhouseCoopers
--
--
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover -16.64%1.33B-3.57%1.11B25.63%749.51M35.17%319.92M6.78%1.6B-3.49%1.15B-26.22%596.62M-42.79%236.69M-0.03%1.5B0.14%1.19B
Operating income -16.64%1.33B-3.57%1.11B25.63%749.51M35.17%319.92M6.78%1.6B-3.49%1.15B-26.22%596.62M-42.79%236.69M-0.03%1.5B0.14%1.19B
Cost of sales 18.38%-1.01B0.15%-844.68M-34.37%-539.9M-39.03%-223.22M-6.79%-1.23B7.43%-845.93M35.94%-401.79M49.01%-160.56M-5.21%-1.16B-3.12%-913.87M
Other costs -------------------257.79M--------------------
Operating expenses 32.49%-1.01B0.15%-844.68M-34.37%-539.9M-39.03%-223.22M-29.11%-1.49B7.43%-845.93M35.94%-401.79M49.01%-160.56M-5.21%-1.16B-3.12%-913.87M
Gross profit 203.27%325.96M-13.11%263.17M7.59%209.61M27.02%96.7M-68.59%107.48M9.57%302.88M7.34%194.82M-22.97%76.13M-14.44%342.17M-8.57%276.43M
Selling expenses 5.83%-57.55M0.06%-43.93M-6.21%-28.3M-33.82%-16.37M-7.82%-61.11M-126.59%-43.96M-122.22%-26.64M-120.14%-12.23M-96.87%-56.68M5.12%-19.4M
Administrative expenses 1.01%-128.99M0.58%-97.5M6.32%-62.64M7.60%-29.81M15.99%-130.31M25.52%-98.07M26.96%-66.87M34.41%-32.26M10.50%-155.12M-6.81%-131.67M
Impairment and provision 391.67%8.65M------------57.54%-2.96M-------------102.67%-6.98M---6.54M
-Other impairment is provision 391.67%8.65M------------57.54%-2.96M-------------102.67%-6.98M---6.54M
Special items of operating profit -117.00%-3.21M45.60%7.2M-183.27%-7.15M-271.95%-6.82M161.71%18.87M173.01%4.95M757.50%8.59M133.18%3.96M-56.30%7.21M-80.88%1.81M
Operating profit 312.93%144.86M-22.23%128.94M1.47%111.52M22.78%43.7M-152.09%-68.03M37.42%165.79M56.74%109.9M-22.24%35.6M-38.06%130.61M-28.23%120.65M
Financing income 130.59%1.01M479.59%568K557.32%539K322.22%76K338.00%438K36.11%98K41.38%82K0.00%18K-25.93%100K-27.27%72K
Financing cost -32.49%-19.59M-45.19%-14.98M-54.98%-10.06M-67.65%-4.96M-19.72%-14.79M-9.97%-10.31M-1.74%-6.49M9.60%-2.96M14.13%-12.35M15.90%-9.38M
Earning before tax 253.29%126.28M-26.38%114.54M-1.44%102M18.88%38.82M-169.61%-82.38M39.73%155.58M62.23%103.49M-23.21%32.66M-39.81%118.36M-29.11%111.34M
Tax -1,932.54%-35.64M28.42%-31.04M15.46%-25.41M-10.52%-9.93M104.99%1.95M-42.73%-43.36M-75.44%-30.06M20.62%-8.98M25.70%-38.95M29.87%-30.38M
After-tax profit from continuing operations 212.68%90.64M-25.59%83.5M4.30%76.59M22.05%28.9M-201.30%-80.44M38.61%112.22M57.38%73.43M-24.15%23.68M-44.94%79.4M-28.82%80.96M
Earning after tax 212.68%90.64M-25.59%83.5M4.30%76.59M22.05%28.9M-201.30%-80.44M38.61%112.22M57.38%73.43M-24.15%23.68M-44.94%79.4M-28.82%80.96M
Profit attributable to shareholders 212.68%90.64M-25.59%83.5M4.30%76.59M22.05%28.9M-201.30%-80.44M38.61%112.22M57.38%73.43M-24.15%23.68M-44.94%79.4M-28.82%80.96M
Basic earnings per share 212.69%0.0906-25.58%0.08354.36%0.076621.94%0.0289-201.26%-0.080438.52%0.112257.17%0.0734-24.04%0.0237-44.94%0.0794-28.76%0.081
Diluted earnings per share 212.69%0.0906-25.58%0.08354.36%0.076621.94%0.0289-201.26%-0.080438.52%0.112257.17%0.0734-24.04%0.0237-44.94%0.0794-28.76%0.081
Currency Unit TWDTWDTWDTWDTWDTWDTWDTWDTWDTWD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor PricewaterhouseCoopers------PricewaterhouseCoopers------PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg